These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 39401197

  • 1. Identification of key lncRNAs associated with oxaliplatin resistance in colorectal cancer cells and isolated exosomes: From In-Silico prediction to In-Vitro validation.
    Sahebnasagh R, Deli H, Shadboorestan A, Vakili-Ghartavol Z, Salehi N, Komeili-Movahhed T, Azizi Z, Ghahremani MH.
    PLoS One; 2024; 19(10):e0311680. PubMed ID: 39401197
    [Abstract] [Full Text] [Related]

  • 2. In-Silico and In-Vitro Investigation of Key Long Non-coding RNAs Involved in 5-Fluorouracil Resistance in Colorectal Cancer Cells: Analyses Highlighting NEAT1 and MALAT1 as Contributors.
    Sahebnasagh R, Azizi Z, Komeili-Movahhed T, Zendehdel K, Ghahremani MH.
    Cureus; 2024 Aug; 16(8):e66393. PubMed ID: 39246994
    [Abstract] [Full Text] [Related]

  • 3. Functional role of a long non-coding RNA LIFR-AS1/miR-29a/TNFAIP3 axis in colorectal cancer resistance to pohotodynamic therapy.
    Liu K, Yao H, Wen Y, Zhao H, Zhou N, Lei S, Xiong L.
    Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2871-2880. PubMed ID: 29807108
    [Abstract] [Full Text] [Related]

  • 4. Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer.
    Liu T, Zhang X, Du L, Wang Y, Liu X, Tian H, Wang L, Li P, Zhao Y, Duan W, Xie Y, Sun Z, Wang C.
    Mol Cancer; 2019 Mar 19; 18(1):43. PubMed ID: 30890168
    [Abstract] [Full Text] [Related]

  • 5. Novel exosomal miR-46146 transfer oxaliplatin chemoresistance in colorectal cancer.
    Xu Y, Zhu M.
    Clin Transl Oncol; 2020 Jul 19; 22(7):1105-1116. PubMed ID: 31728833
    [Abstract] [Full Text] [Related]

  • 6. Identification of MFI2-AS1, a Novel Pivotal lncRNA for Prognosis of Stage III/IV Colorectal Cancer.
    Luo R, Song J, Zhang W, Ran L.
    Dig Dis Sci; 2020 Dec 19; 65(12):3538-3550. PubMed ID: 31960204
    [Abstract] [Full Text] [Related]

  • 7. miR-506 enhances the sensitivity of human colorectal cancer cells to oxaliplatin by suppressing MDR1/P-gp expression.
    Zhou H, Lin C, Zhang Y, Zhang X, Zhang C, Zhang P, Xie X, Ren Z.
    Cell Prolif; 2017 Jun 19; 50(3):. PubMed ID: 28217977
    [Abstract] [Full Text] [Related]

  • 8. Extracellular Vesicle-derived circular RNAs confers chemoresistance in Colorectal cancer.
    Hon KW, Ab-Mutalib NS, Abdullah NMA, Jamal R, Abu N.
    Sci Rep; 2019 Nov 11; 9(1):16497. PubMed ID: 31712601
    [Abstract] [Full Text] [Related]

  • 9. TGM2, HMGA2, FXYD3, and LGALS4 genes as biomarkers in acquired oxaliplatin resistance of human colorectal cancer: A systems biology approach.
    Cheraghi-Shavi T, Jalal R, Minuchehr Z.
    PLoS One; 2023 Nov 11; 18(8):e0289535. PubMed ID: 37535601
    [Abstract] [Full Text] [Related]

  • 10. Identification and prediction of novel non-coding and coding RNA-associated competing endogenous RNA networks in colorectal cancer.
    Liang Y, Zhang C, Ma MH, Dai DQ.
    World J Gastroenterol; 2018 Dec 14; 24(46):5259-5270. PubMed ID: 30581274
    [Abstract] [Full Text] [Related]

  • 11. Identification of Diagnostic Exosomal LncRNA-miRNA-mRNA Biomarkers in Colorectal Cancer Based on the ceRNA Network.
    Zhao Y, Song X, Song X, Xie L.
    Pathol Oncol Res; 2022 Dec 14; 28():1610493. PubMed ID: 36185995
    [Abstract] [Full Text] [Related]

  • 12. Overexpression of MEG3 sensitizes colorectal cancer cells to oxaliplatin through regulation of miR-141/PDCD4 axis.
    Wang H, Li H, Zhang L, Yang D.
    Biomed Pharmacother; 2018 Oct 14; 106():1607-1615. PubMed ID: 30119236
    [Abstract] [Full Text] [Related]

  • 13. Bioinformatic analysis reveals an exosomal miRNA-mRNA network in colorectal cancer.
    Ma J, Wang P, Huang L, Qiao J, Li J.
    BMC Med Genomics; 2021 Feb 27; 14(1):60. PubMed ID: 33639954
    [Abstract] [Full Text] [Related]

  • 14. Identification of candidate genes and miRNAs for sensitizing resistant colorectal cancer cells to oxaliplatin and irinotecan.
    Poorebrahim M, Sadeghi S, Ghanbarian M, Kalhor H, Mehrtash A, Teimoori-Toolabi L.
    Cancer Chemother Pharmacol; 2020 Jan 27; 85(1):153-171. PubMed ID: 31781855
    [Abstract] [Full Text] [Related]

  • 15. lncRNA-miRNA-mRNA interaction network for colorectal cancer; An in silico analysis.
    Ghasemi T, Khalaj-Kondori M, Hosseinpour Feizi MA, Asadi P.
    Comput Biol Chem; 2020 Dec 27; 89():107370. PubMed ID: 32932199
    [Abstract] [Full Text] [Related]

  • 16. Identification of Novel miRNAs, Targeting Genes, Signaling Pathway, and the Small Molecule for Overcoming Oxaliplatin Resistance of Metastatic Colorectal Cancer.
    Misbah M, Kumar M, Lee KH, Shen SC.
    Biomed Res Int; 2022 Dec 27; 2022():3825760. PubMed ID: 36193307
    [Abstract] [Full Text] [Related]

  • 17. LncRNA CACS15 contributes to oxaliplatin resistance in colorectal cancer by positively regulating ABCC1 through sponging miR-145.
    Gao R, Fang C, Xu J, Tan H, Li P, Ma L.
    Arch Biochem Biophys; 2019 Mar 15; 663():183-191. PubMed ID: 30639170
    [Abstract] [Full Text] [Related]

  • 18. Microarray Analysis of Long Non-coding RNA Expression Profile Associated with 5-Fluorouracil-Based Chemoradiation Resistance in Colorectal Cancer Cells.
    Xiong W, Jiang YX, Ai YQ, Liu S, Wu XR, Cui JG, Qin JY, Liu Y, Xia YX, Ju YH, He WJ, Wang Y, Li YF, Hou Y, Wang L, Li WH.
    Asian Pac J Cancer Prev; 2015 Mar 15; 16(8):3395-402. PubMed ID: 25921151
    [Abstract] [Full Text] [Related]

  • 19. The identification of CRNDE, H19, UCA1 and HOTAIR as the key lncRNAs involved in oxaliplatin or irinotecan resistance in the chemotherapy of colorectal cancer based on integrative bioinformatics analysis.
    Sun F, Liang W, Qian J.
    Mol Med Rep; 2019 Oct 15; 20(4):3583-3596. PubMed ID: 31432188
    [Abstract] [Full Text] [Related]

  • 20. MiR-483-3p regulates oxaliplatin resistance by targeting FAM171B in human colorectal cancer cells.
    Liang H, Xu Y, Zhang Q, Yang Y, Mou Y, Gao Y, Chen R, Chen C, Dai P.
    Artif Cells Nanomed Biotechnol; 2019 Dec 15; 47(1):725-736. PubMed ID: 30861353
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.